Dupont Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,700
Closed -$467K 1775
2021
Q2
$467K Buy
5,700
+1,019
+22% +$83.5K 0.01% 1040
2021
Q1
$445K Sell
4,681
-909
-16% -$86.4K 0.01% 996
2020
Q4
$347K Buy
5,590
+585
+12% +$36.3K 0.01% 988
2020
Q3
$298K Buy
5,005
+571
+13% +$34K 0.01% 975
2020
Q2
$309K Buy
4,434
+3,196
+258% +$223K 0.01% 959
2020
Q1
$56K Buy
+1,238
New +$56K ﹤0.01% 1238
2019
Q3
Sell
-3,418
Closed -$243K 1236
2019
Q2
$243K Sell
3,418
-32,645
-91% -$2.32M 0.01% 1058
2019
Q1
$2.83M Buy
36,063
+10,399
+41% +$815K 0.06% 285
2018
Q4
$2.17M Sell
25,664
-1,074
-4% -$90.9K 0.05% 333
2018
Q3
$4.58M Buy
26,738
+7,568
+39% +$1.3M 0.1% 190
2018
Q2
$2.48M Buy
19,170
+3,382
+21% +$437K 0.06% 297
2018
Q1
$1.63M Sell
15,788
-4,189
-21% -$432K 0.04% 389
2017
Q4
$1.71M Hold
19,977
0.04% 395
2017
Q3
$1.7M Hold
19,977
0.04% 400
2017
Q2
$1.51M Hold
19,977
0.03% 435
2017
Q1
$1.32M Buy
19,977
+6,348
+47% +$419K 0.03% 452
2016
Q4
$864K Buy
13,629
+7,286
+115% +$462K 0.02% 533
2016
Q3
$404K Sell
6,343
-8,373
-57% -$533K 0.01% 591
2016
Q2
$1.1M Sell
14,716
-15,186
-51% -$1.13M 0.02% 421
2016
Q1
$2M Hold
29,902
0.05% 319
2015
Q4
$2.02M Hold
29,902
0.05% 337
2015
Q3
$1.6M Buy
29,902
+11,628
+64% +$621K 0.04% 369
2015
Q2
$1.15M Hold
18,274
0.02% 417
2015
Q1
$879K Hold
18,274
0.02% 459
2014
Q4
$607K Hold
18,274
0.01% 529
2014
Q3
$536K Buy
18,274
+7,101
+64% +$208K 0.01% 552
2014
Q2
$434K Buy
+11,173
New +$434K 0.01% 587